Log In
Print
BCIQ
Print
Print this Print this
 

M-enoxaparin, enoxaparin

  Manage Alerts
Collapse Summary General Information
Company Momenta Pharmaceuticals Inc.
DescriptionLow molecular weight heparin
Molecular Target Factor Xa ; Thrombin (Factor IIa) (F2)
Mechanism of ActionAnti-thrombotic/thrombolytic
Latest Stage of DevelopmentMarketed
IndicationDeep vein thrombosis (DVT)
Partner

Novartis AG
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today